The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Gemcitabine (G) + nab-paclitaxel (nab-P) versus G in patients (pts) with advanced pancreatic cancer (PDAC) after FOLFIRINOX: A single center, retrospective review.
 
Edmond Mankee Chan
No Relationships to Disclose
 
Theodore S. Hong
Research Funding - Novartis (Inst)
 
Jeffrey William Clark
Consulting or Advisory Role - Emas pharma
Research Funding - Pfizer (Inst)
 
Lawrence Scott Blaszkowsky
No Relationships to Disclose
 
Jill N Allen
No Relationships to Disclose
 
Andrew Zhu
Consulting or Advisory Role - Amgen; Bristol-Myers Squibb; Celgene; Eisai
Research Funding - Bayer (Inst)
 
Lipika Goyal
No Relationships to Disclose
 
Janet E Murphy
No Relationships to Disclose
 
Eunice L Kwak
Research Funding - Amgen (Inst)
 
Jennifer Y Wo
No Relationships to Disclose
 
David P. Ryan
Honoraria - UpToDate
Consulting or Advisory Role - Medimmune
Patents, Royalties, Other Intellectual Property - McGraw Hill Chapter Royalties
 
Jason Edward Faris
Consulting or Advisory Role - Merrimack; N-of-One
Research Funding - Agios (Inst); Millennium (Inst); Novartis (Inst); Roche (Inst)